Soleus Capital Management, L.P. United Therapeutics Corp Transaction History

Soleus Capital Management, L.P.

$1.44 Billion
Q4 2024

A detailed history of Soleus Capital Management, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 109,394 shares of UTHR stock, worth $33.7 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

109,394

Previous 101,894 7.36%

Holding current value

$33.7 Million

Previous $36.5 Million 5.71%

% of portfolio

2.69%

Previous 3.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $2.61 Million - $3.08 Million	7,500 Added 7.36%	109,394 $38.6 Million
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $12.3 Million - $14.4 Million	-39,605 Reduced 27.99%	101,894 $36.5 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $27 Million - $37.7 Million	-118,250 Reduced 45.52%	141,499 $45.1 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $2.17 Million - $2.57 Million	10,300 Added 4.13%	259,749 $59.7 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $8.1 Million - $9.69 Million	-37,716 Reduced 13.13%	249,449 $54.9 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $9.41 Million - $11 Million	44,430 Added 18.3%	287,165 $64.9 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $21.9 Million - $24.8 Million	106,500 Added 78.17%	242,735 $53.6 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $1.7 Million - $2.2 Million	7,967 Added 6.21%	136,235 $30.5 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $22 Million - $29.9 Million	-106,591 Reduced 45.39%	128,268 $35.7 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $12.3 Million - $14.8 Million	-60,682 Reduced 20.53%	234,859 $49.2 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $1.8 Million - $2.49 Million	-10,309 Reduced 3.37%	295,541 $69.6 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $23.5 Million - $30.3 Million	141,550 Added 86.15%	305,850 $54.9 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $11.5 Million - $13.5 Million	62,500 Added 61.39%	164,300 $35.5 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $18.3 Million - $21.9 Million	101,800 New	101,800 $18.8 Million

Others Institutions Holding UTHR

# of Institutions

725

Shares Held

40.2M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. United Therapeutics Corp Transaction History